Ensign Peak Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $367K | Hold |
39,169
| – | – | ﹤0.01% | 1627 |
|
|
2025
Q1 | $278K | Hold |
39,169
| – | – | ﹤0.01% | 1650 |
|
|
2024
Q4 | $457K | Buy |
39,169
+1,100
| +3% | +$12.8K | ﹤0.01% | 1625 |
|
|
2024
Q3 | $782K | Buy |
38,069
+2,050
| +6% | +$42.1K | ﹤0.01% | 1453 |
|
|
2024
Q2 | $806K | Buy |
36,019
+6,850
| +23% | +$153K | ﹤0.01% | 1418 |
|
|
2024
Q1 | $802K | Sell |
29,169
-1,471
| -5% | -$40.5K | ﹤0.01% | 1462 |
|
|
2023
Q4 | $934K | Hold |
30,640
| – | – | ﹤0.01% | 1425 |
|
|
2023
Q3 | $969K | Hold |
30,640
| – | – | ﹤0.01% | 1228 |
|
|
2023
Q2 | $1.25M | Hold |
30,640
| – | – | ﹤0.01% | 1086 |
|
|
2023
Q1 | $1.14M | Hold |
30,640
| – | – | ﹤0.01% | 1138 |
|
|
2022
Q4 | $1.07M | Buy |
30,640
+13,900
| +83% | +$485K | ﹤0.01% | 1107 |
|
|
2022
Q3 | $937K | Sell |
16,740
-77,677
| -82% | -$4.35M | ﹤0.01% | 1104 |
|
|
2022
Q2 | $4.89M | Buy |
94,417
+78,277
| +485% | +$4.05M | 0.01% | 547 |
|
|
2022
Q1 | $1.17M | Hold |
16,140
| – | – | ﹤0.01% | 1109 |
|
|
2021
Q4 | $1.91M | Buy |
+16,140
| New | +$1.91M | ﹤0.01% | 978 |
|